<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe a novel continuous B-cell line (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>-90) derived from a patient with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and originating from spontaneous <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> with the Epstein-Barr virus (EBV) </plain></SENT>
<SENT sid="1" pm="."><plain>The patient progressed to <z:hpo ids='HP_0011009'>acute</z:hpo> myeloblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) 5 months after clinical <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>-90 is of clonal origin as indicated by the presence of immunoglobulin (Ig) gene rearrangements, monoclonal surface immunoglobulins, and a single DNA restriction fragment corresponding to the EBV genomic termini </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>-90 cells also express a number of myelomonocytic markers, including alpha-naphthyl <z:chebi fb="49" ids="30089,47622">acetate</z:chebi> esterase (ANAE), coagulation factor XIII, and CD68 antigen </plain></SENT>
<SENT sid="4" pm="."><plain>Moreover, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>-90 cells constitutively express the c-fms proto-oncogene <z:chebi fb="2" ids="33699">mRNA</z:chebi> as the patient's blast cells did </plain></SENT>
<SENT sid="5" pm="."><plain>Whereas a <z:mp ids='MP_0004027'>trisomy</z:mp> 11 (+11) was found in the patient's bone marrow cells, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>-90 cells had a <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype initially, but at 4 months showed two different and independent chromosomal abnormalities: 90, XX, -Y, -Y, t(9;16) (q11;p13), and 90, XX, -Y, -Y, t(17;18) (p13;q21), the latter possibly involving the p53 (17,p13) and bcl-2 (18, q21) proto-oncogenes </plain></SENT>
<SENT sid="6" pm="."><plain>The early development of these chromosomal aberrations is consistent with a genetic instability of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>-90 cells </plain></SENT>
<SENT sid="7" pm="."><plain>Expression of bi-lineage markers and genetic instability may suggest that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>-90 cells originated from transformation of a myelodysplastic progenitor cell capable of both myeloid and B-cell differentiation </plain></SENT>
<SENT sid="8" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>-90 cell line might be useful in a number of studies, including the possible role of c-fms in cell differentiation, pathogenetic mechanisms of human <z:e sem="disease" ids="C0026986" disease_type="Neoplastic Process" abbrv="MDS">preleukaemia</z:e> and lineage promiscuity in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
</text></document>